IRADIMED CORP

For the period ended Dec 31, 2025. Filed Mar 6, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 6, 2026

IRMD$86.94+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets

· · · · · · ·
· · December 31, · · December 31,
· · 2025 · · 2024
ASSETS · · · · · ·
Current assets: · · · · · ·
Cash and cash equivalents	$51,159	$52,234
Accounts receivable, net of allowance for credit losses of $191 as of December 31, 2025, and $274 as of December 31, 2024	13,667	10,556
Inventory, net	11,620	10,402
Prepaid expenses and other current assets	4,757	2,050
Total current assets	81,203	75,242
Property and equipment, net	23,856	16,811
Intangible assets, net	3,384	3,099
Deferred tax asset, net	94	2,820
Other assets	239	354
Total assets	$108,776	$98,326
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,820	$1,896
Accrued payroll and benefits	3,218	3,772
Warranty reserve	144	118
Deferred revenue	2,871	2,260
Other current liabilities	313	466
Accrued income taxes	1,814	—
Total current liabilities	10,180	8,512
Deferred revenue, non-current	3,978	2,993
Operating lease liabilities, non-current	—	2
Total liabilities	$14,158	$11,507
Stockholders’ equity:
Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,781,774 shares issued and outstanding as of December 31, 2025, and 12,709,860 shares issued and outstanding as of December 31, 2024	$1	$1
Additional paid-in capital	30,386	30,027
Retained earnings	64,231	56,791
Total stockholders' equity	94,618	86,819
Total liabilities and stockholders’ equity	$108,776	$98,326

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.